Our work with the Roth and Kash Labs characterizing a novel DREADD (Designer Receptor Exclusively Activated by Designer Drugs) based on the kappa opioid receptor was published in Neuron this week. This research was featured on the UNC School of Medicine Vital Signs webpage and is gathering national and international attention. See the links below for press coverage.
UNC School of Medicine: A BRAIN Initiative first: new tool can switch behavior ‘on’ and ‘off’
National Institutes of Health: Souped-up remote control switches behaviors on-and-off in mice
In the United States: Obama’s BRAIN Initiative yields first study results